Organon & Co. (OGN)
NYSE·Healthcare·Drug Manufacturers - General
$13.32
+1.14%
Mkt Cap $2.30B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $1.53B | $1.51B | -1.81% | $0.73 | $0.63 | -13.70% | — | — |
| Q4 2025 Nov 10, 2025 | $1.52B | $1.60B | +5.26% | $0.93 | $1.01 | +8.60% | — | — |
| Q3 2025 Aug 5, 2025 | $1.56B | $1.59B | +2.07% | $0.94 | $1.00 | +6.38% | — | — |
| Q2 2025 May 1, 2025 | $1.54B | $1.51B | -1.52% | $0.89 | $1.02 | +14.61% | — | — |
| Q1 2025 Feb 13, 2025 | $1.59B | $1.59B | -0.02% | $0.92 | $0.90 | -2.17% | — | — |
| Q4 2024 Oct 31, 2024 | $1.56B | $1.58B | +1.16% | $0.90 | $0.87 | -3.33% | — | — |
| Q3 2024 Aug 6, 2024 | $1.63B | $1.61B | -1.46% | $1.06 | $1.12 | +5.66% | — | — |
| Q2 2024 May 2, 2024 | $1.57B | $1.62B | +3.46% | $0.97 | $1.22 | +25.77% | — | — |
| Q1 2024 Feb 15, 2024 | $1.55B | $1.60B | +3.31% | $0.80 | $0.88 | +10.00% | — | — |
| Q4 2023 Nov 2, 2023 | $1.58B | $1.52B | -3.92% | $1.04 | $0.87 | -16.35% | — | — |
| Q3 2023 Aug 8, 2023 | $1.58B | $1.61B | +2.09% | $0.97 | $1.31 | +35.05% | — | — |
| Q2 2023 May 4, 2023 | $1.58B | $1.54B | -2.43% | $1.18 | $1.08 | -8.47% | — | — |
| Q1 2023 Feb 16, 2023 | $1.52B | $1.49B | -2.52% | $0.85 | $0.81 | -4.71% | — | — |
| Q4 2022 Nov 3, 2022 | $1.51B | $1.54B | +1.51% | $1.12 | $1.32 | +17.86% | — | — |
| Q3 2022 Aug 4, 2022 | $1.53B | $1.58B | +3.41% | $1.16 | $1.25 | +7.76% | — | — |
| Q2 2022 May 5, 2022 | $1.52B | $1.57B | +3.14% | $1.30 | $1.65 | +26.92% | — | — |
| Q1 2022 Feb 17, 2022 | $1.57B | $1.60B | +1.96% | $1.25 | $1.37 | +9.60% | — | — |
| Q4 2021 Nov 11, 2021 | $1.34B | $1.60B | +19.01% | $1.44 | $1.67 | +15.97% | — | — |
| Q3 2021 Aug 12, 2021 | $1.59B | $1.59B | +0.00% | $1.40 | $1.72 | +22.86% | — | — |
| Q2 2021 Jun 21, 2021 | — | $1.51B | — | $1.52 | $1.58 | +3.95% | — | — |